Rocket Pharmaceuticals (RCKT) Misses Q1 EPS by 2c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q1 EPS of ($0.42), $0.02 worse than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Avis Budget Group reaches $650M settlement with Pentwater Capital
• Apollo Private Credit Fund caps redemptions at 5% - Bloomberg